Loading...
Please wait, while we are loading the content...
Contraception and HIV: what do we know and what needs to be done?
| Content Provider | Semantic Scholar |
|---|---|
| Author | Waters, Laura J. Barton, Simon |
| Copyright Year | 2006 |
| Abstract | The era of highly active antiretroviral therapy (HAART) has been associated with dramatic reductions in the rates of morbidity and mortality associated with HIV infection. In countries with access to HAART the management of HIV has evolved to one where long-term management and related issues form an increasing part of patient care. In recent years the greatest number of new HIV diagnoses in the UK have been amongst heterosexuals and in addition to the huge improvements in the quality of life enjoyed by these individuals reproductive health forms an increasingly important aspect of patient care. For example amongst sero-discordant couples (i.e. where only one partner is HIV-infected) the prevention of HIV transmission is paramount when reviewing contraceptive options. Amongst sero-concordant couples (i.e. where both partners are HIV-infected) the potential for transmitting resistant virus must be considered. The use of HAART is associated with potentially complex interactions with a number of drugs including hormonal contraceptives. In this article we review the contraceptive options available for couples living with HIV infection and in particular review the current knowledge on interactions between HAART and hormonal methods of contraception. (excerpt) |
| File Format | PDF HTM / HTML |
| DOI | 10.1783/147118906775275055 |
| Alternate Webpage(s) | http://jfprhc.bmj.com/content/familyplanning/32/1/10.full.pdf |
| PubMed reference number | 16492326 |
| Alternate Webpage(s) | https://doi.org/10.1783/147118906775275055 |
| Journal | Medline |
| Volume Number | 32 |
| Issue Number | 1 |
| Journal | The journal of family planning and reproductive health care |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
